Erectile dysfunction in common neurological conditions: A narrative review.
Journal
Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica
ISSN: 2282-4197
Titre abrégé: Arch Ital Urol Androl
Pays: Italy
ID NLM: 9308247
Informations de publication
Date de publication:
21 Dec 2020
21 Dec 2020
Historique:
received:
19
05
2020
accepted:
08
06
2020
entrez:
22
12
2020
pubmed:
23
12
2020
medline:
29
6
2021
Statut:
epublish
Résumé
Neurogenic erectile dysfunction (NED) can be defined as the inability to achieve or maintain an erection due to central or peripheral neurologic disease. Neurologic diseases can also affect the physical ability and psychological status of the patient. All these factors may lead to a primary or secondary NED. Medication history plays an important role since there are many drugs commonly used in neurologic patients that can lead to ED. The assessment of NED in these patients is generally evolving with the application of evoked potentials technology in the test of somatic and autonomic nerves, and functional magnetic resonance imaging. With the electrophysiological examinations, neurogenic causes can be determined. These tools allow to categorize neurologic lesion and assess the patient prognosis. The first-line treatment for NED is phosphodiesterase inhibitors. Second-line treatments include intracavernous and intraurethral vasoactive injections. Third-line treatments are penile prostheses. The efficacy and safety of each treatment modality depend on the specific neurologic condition. This review discusses the physiology, pathophysiology, diagnosis, and treatment of ED in multiple peripheral and central neurologic conditions, as well as for future research.
Identifiants
pubmed: 33348971
doi: 10.4081/aiua.2020.4.371
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM